THR-687

· Oxurion

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for THR-687, covering 2023-08-18 to 2023-08-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. [Phase 2]